Drugmaker Perrigo Hires a New CEO -- Update
October 08 2018 - 10:09PM
Dow Jones News
By Maria Armental and Stephen Nakrosis
Perrigo Co. has hired a former food and tobacco industry
executive to lead the company, less than a year after the drugmaker
picked a pharmaceutical and health care manufacturer veteran to
lead a turnaround effort.
Murray S. Kessler, 59 years old, on Monday succeeded Uwe
Röhrhoff as chief executive as Perrigo moves to separate its
prescription pharmaceutical unit, which accounted for about
one-fifth of revenue in 2017.
In announcing his hiring on Monday, Perrigo highlighted Mr.
Kessler's leadership experience in growing consumer-product
companies and managing businesses in a regulated environment.
A Perrigo representative declined to comment beyond a press
release.
Mr. Röhrhoff, previously CEO at Gerresheimer AG, has stepped
down as Perrigo president, CEO and board member but will remain
available to help with the transition, Perrigo said.
"The Board and Uwe mutually agreed the transition was in the
best interest of the Company and, given the previously announced
separation of the Rx business, now is the appropriate time to make
this change," Perrigo Chairman Rolf Classon said in a
statement.
Financial details weren't disclosed.
One the world's largest makers of over-the-counter drugs,
Perrigo's shareholders in 2015 spurned a $26 billion offer from
Mylan NV.
Five months later, Chief Executive Joseph Papa, who had
successfully steered Perrigo through the rejection of Mylan's
hostile takeover bid, left for Valeant Pharmaceuticals
International Inc., now Bausch Health Cos. Mr. Papa was succeeded
by John Hendrickson, a Perrigo veteran who struggled to stabilize
the company and left this year.
Mr. Kessler, who last year became president of the U.S.
Equestrian Federation, is the former chief executive and president
of the Lorillard Tobacco Co. and joined Reynolds American Inc.'s
board after Reynolds, now part of British American Tobacco PLC,
bought Lorillard.
Before joining Lorillard, Mr. Kessler served as vice chairman of
Altria Group Inc. and president and chief executive of UST Inc., a
wholly owned subsidiary of Altria.
Asked how his business experience would help him as president of
the governing body for equestrian sport in the U.S., Mr. Kessler
told the Chronicle of the Horse magazine: "A lot of people who
don't know might worry about the tobacco experience. It's not a
popular industry. But on the other hand it's an industry that gives
you tremendous experience with legislation and with
regulation."
Perrigo's stock, which lags the market with a 16% decline this
year, fell 1.1% to $72 in after-hours trading in New York.
(END) Dow Jones Newswires
October 08, 2018 21:54 ET (01:54 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Altria (NYSE:MO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Altria (NYSE:MO)
Historical Stock Chart
From Apr 2023 to Apr 2024